What is the Jw Life Science Corp. stock price forecast?

Jw Life Science Corp. is currently trading at ₩11,530. View real-time AI analysis on Alpha Lenz.

What is Jw Life Science Corp. insider trading activity?

View the latest insider trading data for Jw Life Science Corp. on Alpha Lenz.

What is Jw Life Science Corp.'s P/E ratio?

Jw Life Science Corp.'s P/E ratio is 6.4.

Jw Life Science Corp.

KRX · 234080

₩11,530+50(+0.44%)Market closed

Ask about Jw Life Science Corp.'s future dividend policy...

Alpha Chat Insight

“Jw Life Science Corp. trades at a P/E of 6.4 (undervalued) with solid ROE of 13.6%. 3Y revenue CAGR of 10.9% highlights clear growth momentum.”

Ask for details →

Company Overview

JW Life Science Corp. is a prominent player in the pharmaceutical and healthcare manufacturing sector. Specializing in the production of intravenous solutions and nutritional supplements, the company addresses critical healthcare needs by providing essential medical supplies widely used in hospitals and clinics. JW Life Science Corp. also engages in R&D, focusing on innovative drug formulations and delivery systems. This company significantly impacts the pharmaceutical industry by enhancing patient care standards and ensuring the reliability of medical supplies. As a key supplier to the healthcare industry, their product range supports both acute and long-term healthcare services, making them an indispensable partner to medical institutions globally. Headquartered in South Korea, JW Life Science Corp. contributes to advancing healthcare quality through its commitment to safety and efficacy in product development and manufacturing.

CEO노정열

Websitehttps://www.jw-lifescience.co.kr

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees301

Company Statistics

FY 2025

Profile

₩182,572,407,620Market Cap

₩257,829,408,640Revenue

15.83MShares Out

301Employees

Margins

28.05%Gross

20.70%EBITDA

12.89%Operating

12.31%Pre-Tax

11.09%Net

Valuation

6.38P/E

0.83P/B

0.71EV/Sales

4.21EV/EBITDA

6.74P/FCF

Growth (CAGR)

10.92%Rev 3Yr

7.04%Rev 5Yr

7.06%Op Inc 3Yr

-3.37%Op Inc 5Yr

24.12%Net Inc 3Yr

10.58%Net Inc 5Yr

Returns

8.89%ROA

13.59%ROE

10.75%ROIC

Financial Health

₩8,378,876,180Cash & Cash Equivalents

₩89,248,850,800Net Debt

44.26%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Jw Life Science Corp. trades at a P/E of 6.4 (undervalued) with solid ROE of 13.6%. 3Y revenue CAGR of 10.9% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Jw Life Science Corp. (ticker: 234080) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 301 employees. Market cap is $182.6B.

The current price is ₩11,530 with a P/E ratio of 6.38x and P/B of 0.83x.

ROE is 13.59% and operating margin is 12.89%. Annual revenue is $257.8B.